151 related articles for article (PubMed ID: 15247932)
1. A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation.
Grigg AP; Brown M; Roberts AW; Szer J; Slavin MA
Bone Marrow Transplant; 2004 Sep; 34(5):447-53. PubMed ID: 15247932
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
3. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Marr KA; Crippa F; Leisenring W; Hoyle M; Boeckh M; Balajee SA; Nichols WG; Musher B; Corey L
Blood; 2004 Feb; 103(4):1527-33. PubMed ID: 14525770
[TBL] [Abstract][Full Text] [Related]
6. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
8. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.
El Cheikh J; Castagna L; Wang L; Esterni B; Faucher C; Furst S; Duran S; Berger P; Ranque S; Mohty M; Blaise D
Hematol Oncol Stem Cell Ther; 2010; 3(4):167-73. PubMed ID: 21150235
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
12. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
13. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.
Foot AB; Veys PA; Gibson BE
Bone Marrow Transplant; 1999 Nov; 24(10):1089-93. PubMed ID: 10578159
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melbourne Hospital experience.
Grigg A
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():75-80. PubMed ID: 11801586
[TBL] [Abstract][Full Text] [Related]
16. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
[TBL] [Abstract][Full Text] [Related]
17. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
[TBL] [Abstract][Full Text] [Related]
18. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies.
Todeschini G; Murari C; Bonesi R; Pizzolo G; Amaddi G; Ambrosetti A; Cerù S; Piacentini I; Martini N; Montresor P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):614-8. PubMed ID: 8223660
[TBL] [Abstract][Full Text] [Related]
19. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
20. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
